Transparency data

Aggregate net sales and payment information: November 2021

Published 20 January 2022

Table 1: unaudited sales reports measured sales

Aggregate net sales subject to the affordability mechanism (measured sales):

Year 2019 voluntary scheme Statutory scheme Parallel imports Total
2018 贈8,847馨 贈1,654馨 贈771馨 贈11,272馨
2019 Q1 贈2,195馨 贈407馨 贈183馨 贈2,785馨
2019 Q2 贈2,178馨 贈422馨 贈170馨 贈2,770馨
2019 Q3 贈2,304馨 贈419馨 贈165馨 贈2,888馨
2019 Q4 贈2,400馨 贈423馨 贈179馨 贈3,003馨
2019 贈9,101馨 贈1,671馨 贈697馨 贈11,470馨
2020 Q1 贈2,755馨 贈99馨 贈191馨 贈3,045馨
2020 Q2 贈2,402馨 贈95馨 贈176馨 贈2,673馨
2020 Q3 贈2,614馨 贈87馨 贈199馨 贈2,899馨
2020 Q4 贈2,951馨 贈98馨 贈200馨 贈3,249馨
2020 贈10,719馨 贈379馨 贈766馨 贈11,863馨
2021 Q1 贈2,725馨 贈93馨 贈177馨 贈2,995馨
2021 Q2 贈2,816馨 贈100馨 贈192馨 贈3,108馨
2021 Q3 贈3,072馨 贈103馨 贈198馨 贈3,373馨

Table 1 notes

  1. Table 1 sets out aggregate information about measured sales subject to the affordability mechanism. It includes information received on parallel imports, and information from audited annual sales reports and unaudited quarterly sales reports provided by members of the 2019 voluntary scheme and the statutory scheme.
  2. The baseline for measured sales in respect of the statutory scheme and parallel imports has been calculated in accordance with Annex 4, paragraph 1 of the 2019 voluntary scheme.
  3. Measured sales is defined in the glossary of the 2019 voluntary scheme for branded medicines pricing and access as sales of scheme products by scheme members, statutory scheme sales and parallel import sales, but excluding exemptions from measured sales.
  4. Figures for the 2019 voluntary scheme reflect any audited sales reports received. Annual totals from 2019 onwards for the statutory scheme reflect any audited sales reports received.

Measured sales in any particular period reflect all relevant scheme members in either the 2019 voluntary scheme or statutory scheme during that period. For example, several companies moved from the statutory scheme to the voluntary scheme at the start of 2020. Those companies measured sales will appear under the statutory scheme in 2019 but the voluntary scheme in 2020.

Table 2: 2019 voluntary scheme sales reports eligible sales and resulting total scheme payments

Period Aggregate eligible sales (column 1) Resulting aggregate scheme payments (column 2)
2019 贈8,806馨 贈845馨
2020 Q1 贈2,551馨 贈150馨
2020 Q2 贈2,289馨 贈135馨
2020 Q3 贈2,494馨 贈147馨
2020 Q4 贈2,741馨 贈162馨
2020 贈10,071馨 贈594馨
2021 Q1 贈2,450馨 贈125馨
2021 Q2 贈2,636馨 贈134馨
2021 Q3 贈2,906馨 贈148馨

Table 2 notes

Table 2, which is derived from unaudited quarterly sales reports and any audited annual sales reports received from members of the 2019 voluntary scheme, sets out aggregate information showing eligible sales covered by the scheme payment and the resulting scheme payments.

There are 2 columns of information:

  • column 1: aggregate eligible sales
  • column 2: resulting aggregate scheme payments due for the respective periods

Note: eligible sales is defined in the glossary of the 2019 voluntary scheme as sales of scheme products but excluding exemptions from eligible sales. The percentage payment applies to these sales. Eligible sales excludes certain types of sales, including the first 贈5 million of sales by a medium-sized company and new active substance (NAS) sales. Both of these sales categories are, however, included in measured sales and, therefore, the calculation of the overall sum to be repaid across all scheme members.

Table 3: statutory scheme sales reports net sales covered by the statutory scheme payment and resulting payments

Statutory scheme payment and resulting payments 2019 Jan to Mar 2020 Apr to Jun 2020 Jul to Sep 2020 Oct to Dec 2020 2020
Aggregate net sales covered by the applicable annual statutory scheme payment (a) 贈633馨 贈5馨 贈7馨 贈10馨 贈11馨 贈34馨
Resulting aggregate statutory scheme payment (b) 贈63馨 贈1馨 <贈1馨 贈1馨 贈1馨 贈2馨
Net sales of extant frameworks and public contracts subject to 7.8% payment (c) 贈308馨 贈4馨 贈4馨 贈4馨 贈5馨 贈17馨
Resulting statutory scheme 7.8% payment (d) 贈24馨 <贈1馨 <贈1馨 <贈1馨 <贈1馨 贈1馨
Total resulting statutory scheme payment (b + d) 贈87馨 贈1馨 贈1馨 贈1馨 贈1馨 贈4馨
Statutory scheme payment and resulting payments Jan to Mar 2021 Apr to Jun 2021 Jul to Sep 2021
Aggregate net sales covered by the applicable annual statutory scheme payment (a) 贈8馨 贈17馨 贈86馨
Resulting aggregate statutory scheme payment (b) 贈1馨 贈2馨 贈9馨
Net sales of extant frameworks and public contracts subject to 7.8% payment (c) 贈4馨 贈4馨 贈5馨
Resulting statutory scheme 7.8% payment (d) <贈1馨 <贈1馨 <贈1馨
Total resulting statutory scheme payment (b + d) 贈1馨 贈2馨 贈10馨

Table 3 notes

Table 3 is derived from audited and unaudited statutory scheme sales reports. It sets out aggregate unaudited quarterly information showing net sales covered by the statutory scheme payment and the resulting payments.

General notes

Note 1: the information in all tables is that held on the Department of Health and Social Cares database at 17 November 2021.

Note 2: totals may not sum due to rounding.

Note 3: all tables are subject to future correction, such as where audited data replaces best available data, and will be updated at each quarterly publication point to reflect the latest available information. The audit and reconciliation arrangements are set out in paragraphs 4.26 to 4.31 of the 2019 voluntary scheme. The statutory scheme audit requirements are set out at paragraph 23 of the .